Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy.

Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy.

Item
http://www.wikidata.org/entity/Q37451733
Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancersuPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery3D tumor tissue analogs and their orthotopic implants for understanding tumor-targeting of microenvironment-responsive nanosized chemotherapy and radiation.Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis.Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform.Drug delivery systems for ovarian cancer treatment: a systematic review and meta-analysis of animal studies.Preparation and antitumor effect of a toxin-linked conjugate targeting vascular endothelial growth factor receptor and urokinase plasminogen activator.Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer.Antibody-based PET of uPA/uPAR signaling with broad applicability for cancer imaging.miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer.Increased expression of uPA, uPAR, and PAI-1 in psoriatic skin and in basal cell carcinomas.Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.
P2860

Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy.

Item
http://www.wikidata.org/entity/Q37451733
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Urokinase plasminogen activato ...... novel ovarian cancer therapy.
@en
Urokinase plasminogen activato ...... novel ovarian cancer therapy.
@nl
type
label
Urokinase plasminogen activato ...... novel ovarian cancer therapy.
@en
Urokinase plasminogen activato ...... novel ovarian cancer therapy.
@nl
prefLabel
Urokinase plasminogen activato ...... novel ovarian cancer therapy.
@en
Urokinase plasminogen activato ...... novel ovarian cancer therapy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Urokinase plasminogen activato ...... novel ovarian cancer therapy.
@en
P2093
P2860
P304
P31
P356
10.1158/1535-7163.MCT-13-0204
P433
P478
P50
P577
P5875
P698
P921
P932